| Website | cappella-med.com |
| Category | Consumer Electronics/Devices |
| Phone | +353 (0) 91 758939 |
| Employees | |
| Founded | 2005 |
| TOTAL | $22.4M |
| VENTURE FUNDING TOTAL | $22.4M |
| Series D, 10/10 PolyTechnos Venture Partners ACT Venture Capital Fountain Healthcare Partners Mitsui Ventures Kreos Capital | €10.5M |
| Venture Round, 2/11 | $7.1M |
Cappella, Inc., a Dover, Del.- and Galway, Ireland-based medical device company that is developing novel solutions for the treatment of Complex Coronary Artery Disease (CAD) and specifically bifurcation vascular disease.
The company was founded in 2004 by Antonio Columbo, M.D., Chief of Invasive Cardiology at San Raffaele Hospital in Milan, Italy, and Ascher Shmulewitz, M.D., Ph.D., a cardiologist, medical device entrepreneur and founder of NeoVision, Xcardia and Labcoat Ltd., and established its European headquarters in Galway in 2005.
